MENU
BCAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioAtla (BCAB) Ownership - Who owns BioAtla?

BioAtla Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.88M
P/E Ratio
N/A
Total Cash
18.21M
Projected Growth
N/A
Total Debt
6.05M
Revenue
11M
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
0.20 USD as % of share price

Fundamentals

BCAB
Capitalization
23.9M
P/E Ratio
N/A
Risk (Beta)
0.31
Dividend Yield
N/A
Total Cash
18.2M
Total Cash/Share
0.31
Total Debt
6.05M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.20%
Revenue
11M
ROE
N/A
Book Value
-16.75M
P/B Ratio
37.74
Cash Flow
N/A
Earnings
-1.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
1.24
Current Revenue Per Employee
169230.77
Dividends Per Share - Security
N/A
EBITDA
-63.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-124.29
Shares Held By Institutions
6.42M
Shares Outstanding - Current
58.7M
Total Liabilities
43.9M
Total Volume MTD
N/A
Value
-1
Gain YTD
-24.425
View a ticker or compare two or three
BCAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BCAB showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11085 Torreyana Road
Phone
+1 858 558-0708
Employees
65
Web
https://www.bioatla.com